234 related articles for article (PubMed ID: 17622600)
1. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
Wasko MC; Hubert HB; Lingala VB; Elliott JR; Luggen ME; Fries JF; Ward MM
JAMA; 2007 Jul; 298(2):187-93. PubMed ID: 17622600
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients.
Bili A; Sartorius JA; Kirchner HL; Morris SJ; Ledwich LJ; Antohe JL; Dancea S; Newman ED; Wasko MC
J Clin Rheumatol; 2011 Apr; 17(3):115-20. PubMed ID: 21441823
[TBL] [Abstract][Full Text] [Related]
3. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
[TBL] [Abstract][Full Text] [Related]
7. Risk of diabetes in patients with rheumatoid arthritis taking hydroxychloroquine.
Di Comite G; Rossi CM
JAMA; 2007 Nov; 298(20):2368-9; author reply 2369-70. PubMed ID: 18042914
[No Abstract] [Full Text] [Related]
8. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
Rodriguez-Rodriguez L; Jover-Jover JA; Fontsere O; Peña-Blanco RC; León L; Fernández-Gutierrez B; Abásolo L
Scand J Rheumatol; 2013; 42(6):433-6. PubMed ID: 23742043
[TBL] [Abstract][Full Text] [Related]
11. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
Chen TH; Lai TY; Wang YH; Chiou JY; Hung YM; Wei JC
QJM; 2019 Oct; 112(10):757-762. PubMed ID: 31218368
[TBL] [Abstract][Full Text] [Related]
13. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis.
Wu CL; Chang CC; Kor CT; Yang TH; Chiu PF; Tarng DC; Hsu CC
Clin J Am Soc Nephrol; 2018 May; 13(5):702-709. PubMed ID: 29661770
[TBL] [Abstract][Full Text] [Related]
15. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
Lillegraven S; Greenberg JD; Reed GW; Saunders K; Curtis JR; Harrold L; Hochberg MC; Pappas DA; Kremer JM; Solomon DH
PLoS One; 2019; 14(1):e0210459. PubMed ID: 30673733
[TBL] [Abstract][Full Text] [Related]
17. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
Unübol M; Ayhan M; Guney E
J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
[No Abstract] [Full Text] [Related]
20. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
